Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-25

Clinical Trial Update: Efficacy of the Brand-name Latanoprost and One of Its Generic Version in Primary Open Angle Glaucoma and Ocular Hypertension [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy of brand-name latanoprost versus a generic latanoprost in primary open-angle glaucoma and ocular hypertension has been ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Latanoprost (Latanoprost)
  • Xalatan (latanoprost)

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: Primary Open Angle Glaucoma, Ocular Hypertension | Phase 4 | Status: TERMINATED